AcariaHealth Highlights National Biosimilars Education Efforts with Three Events

Core Insights - AcariaHealth, in collaboration with NASP and Reuters Events, hosted three educational events in October 2025 focused on the U.S. biosimilars landscape, aiming to enhance biosimilar utilization and patient outcomes [1][2] - The sessions provided healthcare professionals with actionable guidance to overcome barriers to biosimilar access and improve patient care [1][2] Event Summaries - The NASP Lunch & Learn session titled "Biosimilars Unveiled: Strategies for Success in Specialty Pharmacy" addressed foundational biosimilar education and strategies for overcoming challenges in specialty pharmacy [1] - The Reuters Events panel discussed biosimilar adoption trends, policy considerations, and access challenges, with insights from industry leaders on patient care and operational readiness [1] - The AcariaHealth webinar focused on biosimilar fundamentals, misconceptions, and strategies for successful integration across care settings [2] Key Insights Across All Sessions - Current regulatory and market updates influencing biosimilar adoption were discussed, along with communication strategies to reduce provider and patient hesitancy [4] - System-level considerations, including substitution rules, payer dynamics, and workflow optimization, were highlighted as critical factors for successful biosimilar integration [4] Company Overview - AcariaHealth is a national specialty pharmacy that supports patients with complex conditions through personalized care and clinical expertise, leveraging the resources of Centene Corporation [2][5]